Literature DB >> 1774453

Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia.

H Tamai1, O Mizuno, A Takaki, K Kiyohara, G Komaki, S Matsubayashi, K Kuma, L F Kumagai, S Nagataki.   

Abstract

Since the secretion of PRL is regulated by the hypothalamic-pituitary axis, an increase in large molecular size PRL in the serum is most likely due to secretion by the pituitary itself. The present study was performed to investigate the possible occurrence of PRL heterogeneity in 128 subjects with menstrual disorder in conjunction with hyperthyroxinemia (88 with untreated Graves' disease, 40 with subacute thyroiditis) and 50 age- and sex-matched healthy controls. All 128 patients in this study were suffering from amenorrhea or oligomenorrhea at the time of their initial visit. PRL heterogeneity was found in the sera of 5 of 88 (5.7%) patients with untreated Graves' disease, in 2 of 40 (5.0%) patients with subacute thyroiditis, but in none of the normal controls. PRL heterogeneity remained essentially unchanged in patients with Graves' disease over 6 months of treatment; however, in patients with subacute thyroiditis, either big-big PRL or big PRL decreased significantly along with a corresponding increase in little PRL associated with recovery from the illness within 6 months. The menstrual disorders in all patients were restored to normal after restoration to a euthyroid state. The underlying cause of the occurrence of PRL heterogeneity in patients with menstrual disorder in conjunction with hyperthyroxinemia is not known.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774453     DOI: 10.1007/BF03347893

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone.

Authors:  N H Farkouh; M G Packer; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

2.  Heterogeneity of pituitary and plasma prolactin in man: decreased affinity of "Big" prolactin in a radioreceptor assay and evidence for its secretion.

Authors:  P E Garnier; M L Aubert; S L Kaplan; M M Grumbach
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958

3.  Size heterogeneity of human prolactin in CSF and serum: experimental conditions that alter gel filtration patterns.

Authors:  K A Kiefer; W B Malarkey
Journal:  J Clin Endocrinol Metab       Date:  1978-01       Impact factor: 5.958

4.  Multiple molecular forms of prolactin during pregnancy in women.

Authors:  F Pansini; C M Bergamini; M Malfaccini; G Cocilovo; M Linciano; M Jacobs; B Bagni
Journal:  J Endocrinol       Date:  1985-07       Impact factor: 4.286

5.  Characterization of "big big prolactin" in serum and tumor extract in patients with PRL-secreting tumor.

Authors:  S Ohnami; S Eto; S Ohnami; T Soejima; H Nakata
Journal:  Endocrinol Jpn       Date:  1987-06

6.  Effect of suckling on plasma prolactin and hypothalamic monoamine levels in the rat.

Authors:  F Mena; A Enjalbert; L Carbonell; M Priam; C Kordan
Journal:  Endocrinology       Date:  1976-08       Impact factor: 4.736

7.  Further evidence that big,big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian function.

Authors:  F Larrea; C Villanueva; M Carmen Cravioto; A Escorza; O del Real
Journal:  Fertil Steril       Date:  1985-07       Impact factor: 7.329

8.  Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses.

Authors:  R D Jackson; J Wortsman; W B Malarkey
Journal:  J Clin Endocrinol Metab       Date:  1985-08       Impact factor: 5.958

9.  Circulating big human prolactin: conversion to small human prolactin by reduction of disulfide bonds.

Authors:  R Benveniste; J D Helman; D N Orth; T J McKenna; W E Nicholson; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1979-05       Impact factor: 5.958

10.  Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin.

Authors:  P G Whittaker; T Wilcox; T Lind
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

View more
  1 in total

1.  Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.

Authors:  V Larouche; J A Correa; P Cassidy; C Beauregard; N Garfield; J Rivera
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.